The Collaborative Research Centre TRR332 is a DFG-funded consortium dedicated to develop an improved understanding of neutrophil biology. Our studies will reveal mechanisms of how the tissue environment regulates neutrophil production and phenotypes, how neutrophil activity is controlled intracellularly and how neutrophils function in different disease contexts. In the second funding period we will advance our foundational work towards disease models with relevance for human pathology. Specifically, we will focus on three disease entities with great socioeconomic burden and relevance to neutrophil biology, namely vascular inflammation, cancer, and infection. Such approach will not only reveal important aspects of the fine-tuned regulatory mechanisms of neutrophil activation but also permit the generation of tailored intervention strategies.
News
Events
2nd Diversity, Identity & Fate at Biomedical Frontiers
The BMC Diversity Initiative has invited three distinguished Munich-based scientists to present their current research in translational optoacoustics (Miguel Pleitez), lipid metabolism and metabolic diseases (Susanna Hofmann), and oncolytic virus-based cancer immunotherapeutics (Jennifer Altomonte). They will also share insights into the key experiences and challenges that have defined their careers in research. Meet-the-speaker sessions following the talks will offer opportunities for questions and open discussion.
More information here.
Hybrid event; in München and via Zoom, in the BMC Small lecture Hall (15:00 – 17:45).
Extra
Invited lecture by Jamey Marth (Sanford Burnham Prebys - USA)
Regulation of the Secreted Proteome by Mammalian Lectin Receptors Controls Health and Disease
München
flashlight talk A1
Invited lecture by Mikael Karlsson (Karolinska Institute)
Neutrophil regulation of immunotherapy for cancer is regulated by Type II interferon
MPI Münster Lecture Hall